Skip to navigation bar Skip to breadcrumbs Skip to page content
Envelope icon E-mail Updates Teal square Text size:  a A A
You are here: HomeAnnouncementsAnnouncement Detail

U.S. Preventive Services Task Force Issues Final Recommendation Statement for Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum

The U.S. Preventive Services Task Force (USPSTF) has reaffirmed its 2005 recommendation that all newborns should receive topical eye medication for the prevention of gonococcal ophthalmia neonatorum within 24 hours of birth. This is a Grade A recommendation. The USPSTF concluded that there was no evidence of harms associated with the treatment, and the evidence showed a clear benefit to offering the preventive measure to all newborns. The recommendation is available at http://www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/gonococcal-ophthalmia-neonatorum-preventive-medica.

The USPSTF is a national, independent panel of medical experts that makes recommendations, based on scientific evidence, to primary care doctors and other health care providers about which clinical preventive services they should offer their patients.

Current as of: December 2017

Internet Citation: U.S. Preventive Services Task Force Issues Final Recommendation Statement for Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum. U.S. Preventive Services Task Force. July 2011.
https://www.uspreventiveservicestaskforce.org/Announcements/News/Item/us-preventive-services-task-force-issues-final-recommendation-statement-for-ocular-prophylaxis-for-gonococcal-ophthalmia-neonatorum

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857